戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                       In the data about 1184 patients, the quality score increased st
2 ta about C. elegans genes from WormBase with data about 2005 human and model organism genes from GenA
3 njury Statistics Query and Reporting System, data about 25 firearm state laws implemented in 2009, an
4 gh 28 Swedish biopsy registers, we collected data about 26,995 individuals with CD (equal to villous
5 multaneously imposing all available fluxomic data (about 30 measured fluxes per mutant).
6 ation standards, MTB supports aggregation of data about a cancer model from diverse sources and asses
7   We are increasingly accumulating molecular data about a cell.
8 at the adversary can infer sensitive genomic data about a user from the differentially private result
9                                     Although data about ACS in LMICs are limited, there is a growing
10                                              Data about acute rejection, DSA, and renal function were
11 hildhood and high reoperation rate; however, data about adulthood are scarce.
12 Although aortic dilatation is common in CHD, data about adverse long-term outcomes are limited.
13 was documented before and after imaging, and data about all treatments and PSA levels were collected
14                                     Based on data about annual emissions in U.S. counties and current
15 riod, of which we were able to obtain report data about antecedents for 130 (90%).
16 quality of care globally using country-level data about antenatal, childbirth, and postnatal care int
17 Pase from analysis of available experimental data about ATP hydrolysis and Ca(2+) transport.
18 uctive sectioning, and there is a paucity of data about atrial fiber architecture variability in the
19                Another investigator compiled data about baseline clinical stage, biopsy findings, and
20                                              Data about biodiversity have been scattered in different
21                    METHODS AND Country-level data about BPG shortages were collected using 3 survey a
22 e effects of permanent lesions provide vital data about brain function that are distinct from those o
23 ntic knowledge base for aging by integrating data about C. elegans genes from WormBase with data abou
24 ew is to discuss the most recently published data about calcinosis in connective-tissue diseases with
25                                   Conclusive data about cardiovascular toxicity of nonsteroidal anti-
26                                              Data about cause of death were not available.
27                                   Comparable data about cGMP and the PDE11 GAF domains exist.
28 racticing in inpatient settings and included data about change in patient safety culture or climate a
29                                There are few data about CHIKV infection in kidney transplant recipien
30 e, we present experimental and computational data about cholesterol complexation with gp41 in lipid b
31                                              Data about clinical characteristics, acute coronary synd
32                                              Data about clinical manifestations and laboratory findin
33 database systematically collects statistical data about clinical trials but not raw data; this databa
34 ate plant defence, although there are scarce data about CO production by pathogens, especially nonfun
35   We present a practical method to translate data about community structure into predictive knowledge
36  first histological validation of anatomical data about connection length in the primate brain based
37                                    These new data about cross-talk between STIM1 and STIM2 and their
38 en and their parents or guardians to collect data about cumulative life stress.
39                        There are conflicting data about definitions of confidence.
40  their parents (child-parent dyads) provided data about demographic characteristics, health risk beha
41 equently used CDEs found in the DIM included data about dental anatomy, medications, and items such a
42                              We incorporated data about diabetes incidence from the National Health I
43 ms had been designed to prospectively obtain data about diagnosis and treatment of abnormal acid gast
44 ial long-term morbidity but population-based data about diagnosis rates are scarce.
45                                              Data about diarrhoeal disease in two time windows (aroun
46                     Our study provides novel data about differential roles of Notch ligands in regula
47                                    Long-term data about disease behavior during and after pregnancy a
48 ls should be used to integrate and interpret data about disease causation and pathophysiology.
49                            We also collected data about disease severity and household demographics a
50 n drug repositioning by using existing omics data about diseases, drugs and drug targets.
51 revalence data and highly spatially resolved data about drivers of transmission to make location-spec
52  results is limited by the lack of available data about drug effects among individuals with HIV co-in
53 l number of languages or on limited kinds of data about each language.
54                                   Few safety data about edoxaban in patients undergoing electrical ca
55                                          The data about elderly recipient after living donor liver tr
56                                              Data about end-stage kidney disease patients admitted to
57 s that communicate with the ENS, integrating data about ENS function into a broader view of human hea
58 ch as the ENCODE Project provide a wealth of data about epigenetic features associated with gene regu
59          Families are an underused source of data about errors, particularly preventable AEs.
60 ogical information, hPSCreg stores extensive data about ethical standards regarding cell sourcing and
61 cally been difficult to gather and interpret data about evolution of the Sabin viruses used in OPV in
62 al diagnosis of medulloblastoma and complete data about extent of resection and survival from centres
63 of information technology systems to provide data about falls, staff education and training, and chan
64                 Rapid expansion of available data about G Protein Coupled Receptor (GPCR) dimers/olig
65 ne selection strategy that represents public data about genes as graphs and then analyzes these graph
66                 We apply this methodology to data about genes in the laboratory mouse that are formal
67                       Therefore, prospective data about GERD and its natural history in the general p
68                                     However, data about gut dysbiosis in human NAFLD remain scarce in
69                                  We obtained data about haemoglobin and anaemia for children aged 6-5
70              In this GCTA study, we obtained data about HbA1c concentrations before and during metfor
71  Medicare claims files are a ready source of data about health care utilization and have served as th
72 rdiac resynchronization therapy implant, and data about heart failure hospitalization and mode of dea
73                                      We took data about hip replacements done in England and Wales be
74 US to provide high-resolution spatiotemporal data about hormone distribution in response to plant abi
75        Integration of pathogen genomics with data about host genetics and global transcriptional resp
76  low-income and middle-income countries, and data about household deaths in China from their 1990 and
77 ship programs (ASP) that consider real-world data about how antimicrobials are used to treat patients
78          We describe a method for extracting data about how biomolecule pairs interact from texts.
79 stimation models should incorporate not only data about how internet features map to incidence but al
80 g annually, which typically fails to present data about how well drugs work.
81                    An instance of KaBOB with data about humans and seven major model organisms can be
82                       However, there are few data about hyponatremia developing during hospitalizatio
83                                              Data about IA were available for 17 patients.
84 ed heterogeneity, and substantive amounts of data about important outcomes and patient subgroups were
85 reases with age, but representative national data about incidence and prevalence are limited.
86 y was developed, incorporating questionnaire data about individual and household-level risk factors w
87  (EF), it is the provider who enters medical data about individual patients.
88 aracteristics, and the lack of time-resolved data about individuals' behavior.
89                            Since there is no data about its function in pain and arthritis mechanisms
90 tion, although in children there are limited data about its prevalence and whether it is associated w
91 transplantation (LT); however, there are few data about its prevalence, and none about its pathogenes
92 lly contrast-free procedure, there is scarce data about its real incidence and impact.
93 ion/deletion polymorphism with contradictory data about its role in human immunodeficiency virus type
94                                Nevertheless, data about its safety and reproducibility are scarce.
95 by almost a century, which matches molecular data about its spread.
96                              We also provide data about key genes involved in transcription and trans
97 ly prospective studies that collect detailed data about lifetime opium use and control for a broad ra
98 al dynamics of these processes by collecting data about listeners' brain activity as they hear spoken
99                                     However, data about live virus vaccine effectiveness among health
100 trospective study based on Romanian official data about location, age, gender and comorbidities for C
101                                     However, data about long-term outcomes remain limited, especially
102                        There is a paucity of data about long-term outcomes.
103 ions is considered relatively benign, but no data about long-term progression of this disease have be
104                  We review here the existing data about mammalian host species, comparing and contras
105 sence of detailed structural and biochemical data about McjB and McjC, these studies allow us to prop
106 th laws and policies, and publicly available data about mental health.
107 locating, analyzing, visualizing and sharing data about microbial biology through an advanced web-bas
108                      To obtain environmental data about modifiable features that were present in the
109       These findings, together with previous data about morbidity and mortality for the combination,
110 National Health Interview Survey, and linked data about mortality from 1985 to 2011 for 598 216 adult
111  extensive and manually curated experimental data about NR ligands and structures are provided in the
112 ing for ovarian cancer but provided some new data about observed harms of screening.
113 el production generally work with incomplete data about oil production operations.
114 ed taxonomic classification and quantitative data about organism ultrastructures and interactions.
115 g technologies have yielded a vast amount of data about organisms in environmental samples.
116 ens are finding new life, providing critical data about otherwise hidden impacts of human-caused envi
117                            However, existing data about oxidative metabolism in HD are contradictory.
118                              Epidemiological data about P. ovale attacks from 1993 to 2012 were studi
119 rn Finland Birth Cohort 1986, which contains data about parent-reported motor function at age 8 y and
120 ed a platform to easily access and summarize data about pathogen samples.
121                                              Data about patient demographics and operative, oncologic
122 this multicentre, cohort study, we collected data about patients (age >/=16 years old) with clinicall
123 patients with hypertension, but there are no data about patients in high-risk groups.
124                                   Organizing data about patterning and morphogenesis into a coherent
125 ncy is increasing, although population-based data about perinatal outcomes following in utero exposur
126                                    Proteomic data about platelets have become increasingly available
127 ed United Network for Organ Sharing registry data about posttransplantation survival with pretranspla
128                          There are still few data about potential upstream regulators initiating aber
129 nificantly more residents reported receiving data about practice habits on the Accreditation Council
130  freely-available service mines and displays data about proteins with enzymatic activity from public
131 ed self-report and semi-structured interview data about psychiatric and medical history and other env
132 s with access to vast quantities of clinical data about real-world patients and help achieve higher q
133                                              Data about registry enrollment was collected before and
134                          However, conclusive data about reintubation are lacking.
135                                              Data about relatives were drawn from the Utah Population
136                                To contribute data about replicability in economics, we replicated 18
137                Networks were generated using data about reported high-risk contacts, viral genetic si
138                                              Data about resource use and economic outcomes (quality-a
139 serum samples, spirometry, and questionnaire data about respiratory and reproductive health from thre
140                                              Data about respiratory coinfections with 2009 pandemic i
141 eptible to HBV, with comprehensive follow-up data about risky behavior and immunological profiles.
142                                     However, data about rivaroxaban use in routine clinical practice
143 ference standard; and 4) reported sufficient data about sample size and accuracy of methods.
144                                   Additional data about service provision for HIV care could help inf
145    We aimed to consolidate all epidemiologic data about severe periodontitis (SP) and, subsequently,
146                    Contemporary longitudinal data about sex differences in clinical characteristics,
147                                        Using data about shipping, ecoregions, and environmental condi
148     Time-lapse live-cell microscopy provides data about short-term fluctuations in promoter activity,
149                            Here, we compiled data about song plasticity, song characteristics, and ma
150                                              Data about specific KRAS mutations for 331 patients who
151  many commentators, that we need: (1) better data about standards of living, psychological preference
152 ective Bronsted acid catalysis, experimental data about structures and activation modes of substrate/
153                   Paired reviewers extracted data about study characteristics and assessed biases.
154                   We extracted summary-level data about study characteristics and the outcomes of maj
155                  One investigator abstracted data about study design and quality, psychosocial charac
156                      Investigators extracted data about study populations, designs, and outcomes and
157 est growing population in the United States, data about substance-related disorders among adolescents
158    This document provides a synthesis of the data about T2MI to assist clinicians' understanding of i
159 eviews the recent evidence that has provided data about temporal aspects of prognosis in epilepsy and
160 ecause human tissue can only provide limited data about temporal patterns of change.
161 ed standardized abstraction forms to extract data about test performance for detecting cervical intra
162                        There are conflicting data about the ability of peer review percentile ranking
163                                 In addition, data about the accuracy of urine cytology for the detect
164                       A near symmetry of the data about the angle of -40 degrees and a "turnover" in
165 inearity-reproducibility, providing reliable data about the antioxidant capacity of foods under physi
166 n D may protect against several cancers, but data about the association between circulating vitamin D
167 r modeling studies were performed to acquire data about the binding modes of the inhibitors.
168                    Despite its popular uses, data about the bioaccessibility of Se-AAs from Se-Chlore
169 date that the experiments provide meaningful data about the biomolecular process in question; analyzi
170         Neuroimaging has provided compelling data about the brain.
171 makers in ICUs are common, but there are few data about the causes and clinical consequences.
172  The Office for National Statistics provided data about the coding of individual cause of death certi
173                           There is a lack of data about the comparative efficacy of oxytocin and subl
174 here is relatively little neuropsychological data about the consequences of focal lesions.
175                Here, we examine the existing data about the different functions of the Par complex.
176                               Here we review data about the distribution of activity across neuronal
177 -old infants (N = 83) rationally used sparse data about the distribution of outcomes among agents and
178                        These methods extract data about the dynamics of a cyclical process from a sin
179 a systematic review of studies that reported data about the effect of PVR in patients with repaired t
180                                        Field data about the effect of soil pH on phosphorus (P) cycli
181 s are prone to nonrecovery, but there are no data about the effectiveness of retreatment for these pr
182         In this regard, there are compelling data about the effects of EBV latent membrane proteins (
183                          However, real-world data about the efficacy and safety of SL8 are largely mi
184 ort for intervention will rely on convincing data about the endemic burden of HEV disease, particular
185                  However, there are very few data about the environmental fate of these new products,
186                           We review existing data about the epidemiology of nosocomial diarrhea and s
187  of seasonal influenza hospitalizations, but data about the epidemiology of severe influenza among pr
188 iterature as well as the currently available data about the evaluation of visual function, an algorit
189 logy have yielded an unprecedented amount of data about the evolutionary relationships and functional
190          Large gaps exist in epidemiological data about the extent of drug use worldwide and much of
191 oimaging studies have produced contradictory data about the extent to which specific regions of the f
192                                     However, data about the frequency and risk factors of long-term p
193                         There are hardly any data about the frequency of CD4(+)CD25(+)Foxp3(+) regula
194                       However, there are few data about the frequency of demanding patients, clinical
195         The Gene Ontology project integrates data about the function of gene products across a divers
196  study indicates the importance of including data about the habitat modification of a community, to b
197 f these activities represent a new source of data about the health of populations, but which is curre
198                     Very recent experimental data about the immunopathology and the determinants of a
199                       However, there are few data about the impact of low flow on outcomes following
200 eview, we summarise the available literature data about the in vitro antibacterial effects of the mai
201                            There are limited data about the incidence and indications for late allogr
202                                              Data about the incidence of a range of cancer types from
203 n their concentrations in raw matrix and the data about the influence of cooking on antibiotics resid
204                                              Data about the influence of the type of sedation on yiel
205 eward have been identified, but quantitative data about the information carried by local field potent
206    Moreover, due to the paucity of published data about the issue, future multicenter international s
207 r integrated genetic, genomic and biological data about the laboratory mouse.
208                        There is currently no data about the learning curve of L-LLS.
209   We included studies that reported original data about the lifetime prevalence of DSM-III and DSM-IV
210 any important drug targets lack experimental data about the ligand bioactivities; this is particularl
211 pidemic is often an underdetermined problem: data about the location and timings of infections can be
212                                     However, data about the long-term effectiveness of ablation in pa
213 elberg bromeliads and they provide base-line data about the long-term effects of fragmentation in pla
214 ity, and flow cytometry measurements provide data about the long-term kinetics, because isolated subp
215                       There are a paucity of data about the long-term natural history of adult Wolff-
216                          There is paucity of data about the molecular basis of ADH among ethnic group
217  developers of these assays will need better data about the molecular mechanisms of resistance.
218                              A wealth of new data about the molecular organization and molecular sign
219 o any one methodology yields only incomplete data about the nature of linguistic representations.
220 se barriers include the lack of high-quality data about the nature of work (e.g., the dynamic require
221 , while at the same time providing important data about the neural correlates essential for the speci
222 ield lags due to the lack of microanatomical data about the neuro-muscular systems in this group of a
223  clinical settings despite limited empirical data about the number and types of incidental results (w
224 Marder, do they apply different standards to data about the number of times research papers have been
225  controls, accompanied by clinical phenotype data about the patients.
226 used for everything from gathering normative data about the pediatric eye to using the technologies t
227                   However, there are limited data about the phenotype and function of tumor-associate
228                    Here we provide the first data about the physical organization of the DA signaling
229                             We provide novel data about the possible origin of moRNAs, although their
230               These results provide relevant data about the potential of pectinase, tannase and combi
231  the single-cell and subcellular levels, and data about the presence of proteins that are detectable
232                                 Heterogenous data about the prognostic impact of atrial fibrillation
233                                  Conflicting data about the protocol of choice for non-surgical perio
234  ART initiation.IMPORTANCE There are limited data about the proviral landscape in children exhibiting
235 186 meeting inclusion criteria and providing data about the region in which they practice; of these,
236  coherent framework a wide range of existing data about the regulation of excitability, feedback inhi
237 ay (PBM) technology, which provides in vitro data about the relative DNA-binding preferences of trans
238                                              Data about the response of hepatitis C virus (HCV) genot
239    In this setting, there are not consistent data about the response to conventional therapies and th
240 t this region provide a remarkable source of data about the rise and fall of these complex polities.
241 rus (HBV) reactivation; however, informative data about the risk of different immunosuppressive regim
242                      Long-term observational data about the risk of infection and biologic therapy co
243 nts with acute coronary syndrome, but recent data about the risk of new-onset diabetes mellitus have
244                            There are limited data about the risk of thrombotic and embolic complicati
245 r compartments, highlighting recent exciting data about the role and regulation of the Vps34 class II
246 ld studies to date have provided conflicting data about the role of EPCR in SM.
247 factors in the etiology of caries and 2) new data about the role of genetics in terms of longitudinal
248                                     Finally, data about the role of NSAIDs in preventing ovulation su
249                        There is a paucity of data about the role of the Nox5 isoform of NADPH oxidase
250 r users from late 2017 merged with nonpublic data about the Russian Internet Research Agency (IRA) fr
251 urn since 30 June 2004, yielding a wealth of data about the Saturn system.
252 ciently provides low-resolution experimental data about the shapes of proteins and their assemblies.
253                                              Data about the significance of (18)F-FDG PET at interim
254        Several new methods provide extensive data about the specificity of transcription factors but
255 d iodized salt and very limited experimental data about the stability of potassium iodate (KIO(3)) or
256 e sensing technologies that deliver detailed data about the structure and thermal composition of envi
257 primary caregiver and teachers also provided data about the student.
258 or occurred in the original article, and new data about the studies cited have come to light.
259            The results provide comprehensive data about the success of this career development progra
260     However, due to the paucity of published data about the topic, some conclusions rely on grey area
261                                More accurate data about the true incidence and clinical impact of AKI
262 owledge that the analyst has gained from the data about the unknown true map.
263                         There are no current data about the use and outcomes of transradial PCI (r-PC
264                                              Data about the use of rivaroxaban in the setting of left
265            Interim safety and immunogenicity data about the vaccine candidate BNT162b1 in younger adu
266       Sensory neurons provide organisms with data about the world in which they live, for the purpose
267  in a biological environment and the lack of data about their biodistributions.
268      Although several devices are available, data about their clinical efficacy are scarce.
269 osal in the market, however there are scarce data about their composition.
270               There is a significant lack of data about their content from some of the main producer
271 ence interventions have been identified, but data about their cost-effectiveness are lacking.
272 s) are high production volume chemicals, but data about their environmental fate are scarce.
273 d even in richer countries there are limited data about their frequency, clinical course, or mortalit
274 ed in murine models of infection, functional data about their human counterpart are lacking.
275 of this injury in a normal (lean) state, but data about their role in a steatotic liver are practical
276 f microneedles in dermatology, there are few data about their safety.
277 s can be collected, in addition to automated data about their whereabouts, behaviour, and physiologic
278 r platforms generate substantial behavioural data about themselves and their social ties(1-5).
279  firing fields that match neurophysiological data about these cells and their development in juvenile
280 ity of NPS, there is a paucity of scientific data about these drugs.
281 ChIP-Seq have led to a flood of high-quality data about these epigenomic domains, there remain import
282                           Much epidemiologic data about these pathogens have been collected from comm
283 r function tests do not provide quantitative data about these pathways.
284              The use of available historical data about these predictors to resolve the spatial varia
285      Here we review established and emerging data about these responses.
286 ase reports, to our knowledge, comprehensive data about third-trimester natalizumab exposure are scan
287 ated with poor kidney transplant outcome, no data about this association exist from the current era o
288 studied in some populations but there are no data about this association in the Iranian population.
289 itnessed out-of-hospital cardiac arrest, but data about this intervention in children are limited.
290 ects and integrates genomic and experimental data about this organism in a way that can be readily ac
291 ression, however, there is still conflicting data about this phenomenon.
292  review, available structural and functional data about three such microcins--microcin J25, microcin
293 esults fill an important gap in national HIV data about transgender people with HIV.
294 s of infectious diseases, but the paucity of data about travel behavior and population flux over time
295    We aimed to consolidate all epidemiologic data about untreated caries and subsequently generate in
296                 Because there is conflicting data about upregulation of extracellular TGF-beta levels
297 stems, it is difficult to gather large-scale data about user behavior.
298 le to generate an enormous volume of genomic data about vast numbers of people.
299          Remote access to laboratory quality data about walking speed, duration and distance, gait as
300 statistical evidence from population genetic data about whether one of the two recombination events i

 
Page Top